Business Services Industry
The Seattle Times Business Digest Column.
Knight Ridder/Tribune Business News, January, 2002
The Seattle Times Knight Ridder/Tribune Business News
Jan. 11-- SEATTLE--CORIXA'S STOCK DIVES 16 PERCENT: Investors knocked down Corixa's stock by 16 percent yesterday after the Seattle biotech company faced the latest in a series of regulatory delays holding back its first drug.
Corixa's stock fell $2.39, closing at $12.38 yesterday.
Any rebound in the company's fortune depends squarely on what happens at the Food and Drug Administration. Because the FDA is increasingly being seen as overwhelmed with drug applications, Corixa officials don't know when the agency will schedule a hearing for Bexxar, Corixa's treatment for non-Hodgkin's lymphoma.
Corixa Chief Executive Steve Gillis said Bexxar approval remains the company's...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
